Johns Hopkins Kimmel Cancer Center researchers developed a new technology to overcome the inefficiencies and high error rates common among next-generation sequencing techniques that have previously limited their clinical application.
The study describes how the team developed a blood test, composed of RNA biomarkers, that can distinguish how severe a patient's depression is, their risk of severe depression in the future, and their risk of future bipolar disorder.
The new panel includes SARS-CoV-2 among 19 viral and two bacterial common respiratory pathogens.
A research team has developed a test to determine if bacteria are sick, similar to the one used to test humans for covid-19.
Read More
The HDPCR technology could enable a 5x increase in analytical capacity on existing instruments—which could allow broader global accessibility to precision medicine at an economical cost.
Read More
The Purigen Ionic FFPE Complete Purification Kit consists of 12 chips and a reagent set to perform DNA extraction from 48 samples.
Read More
Reagent shortages during the covid-19 pandemic draw attention to a different method.
Read More
Developing technology ushers in a new era in precision oncology.
Read More
Diagenode offers more than 30 real-time PCR tests that are CE-marked for the detection of bacteria, parasites, and viruses.
Read More
The FDA has approved two comprehensive genomic profiling liquid biopsy tests for use in supporting doctors with their treatment decision-making.
Read More
The Boston team’s methodology allows an apples-to-apples comparison of the various assays’ clinical sensitivity.
Read More
Laboratory staffing and supply shortages are limiting patient access to critical cancer screening tests that guide treatment decisions.
Read More
Rapid adoption of molecular testing in cancer necessitates quality cell line-derived controls.
Read More
Thermo Fisher Scientific is now calling for proposals dedicated to liquid biopsy research. Each proposal may receive an award worth up to $200,000 in reagents and funding.
Read More
The Everlywell Covid-19 Test Home Collection Kit DTC is now authorized for sale directly to consumers online and on shelves at retailers, regardless of symptoms or known exposure.
Read More
The TaqPath Covid-19, Flu A, Flu B Combo Kit is a real-time PCR test for the detection and differentiation of RNA from the SARS-CoV2, influenza A, and influenza B viruses in nasopharyngeal and nasal swabs.
Read More
The Multi-Target Reliance SARS-CoV-2/FluA/FluB RT-PCR and Reliance SARS-CoV-2 RT-PCR Assay Kits are the latest additions to Bio-Rad’s portfolio of products related to covid-19.
Read More
Myriad’s GeneSight test evaluates how variations in multiple genes may influence an individual’s outcomes with certain medications prescribed to treat depression, anxiety, and other psychiatric conditions.
Read More